← All candidates
One insider bought $78.4K in two days.
43 filings on record.
TELATELA Bio, Inc.
NasdaqGM · Healthcare · $53.27M
$1.18
+8.26% today
One insider bought $78.4K in two days.
Led by Capper Joseph H, director.
Price · 1Y · daily● 4 buys◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$53.27M
Float
21.6M
48% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
0.7
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Ew Healthcare Partners Fund 2, L.p.
Bought $4.00M on Nov 17 — 3,604,000 sh @ $1.11, held direct, 47% of their stake.
0 of 1 position beat the S&P
Director
Capper Joseph H
Bought $52.9K on Sep 15 — 50,000 sh @ $1.06, held direct, 48% of their stake.
No completed positions to measure
Chief Executive Officer
Getz Heather C
Bought $10.5K on Aug 14 — 15,000 sh @ $0.6978, held direct, 2.9% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
38 more transactions on Pro →Context
Wall St
$2.25 avg target
+90.7% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 3 quarters beat
Q4 '25−$0.17 act+$0.01
Q3 '25−$0.19 act+$0.01
Q2 '25−$0.22 act−$0.04
Coverage
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25Simply Wall St. · 05-15TELA Bio, Inc. Q1 2026 Earnings Call SummaryMoby · 05-13TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...GuruFocus.com · 05-13TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue EstimatesZacks · 05-12
The file stays open
43 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice